Inspire IVF PCL (BKK:IVF)

Market Cap	431.20M
Revenue (ttm)	106.14M
Net Income (ttm)	13.91M
Shares Out	440.00M
EPS (ttm)	0.04
PE Ratio	24.83
Forward PE	n/a
Dividend	0.02 (2.42%)
Ex-Dividend Date	Mar 13, 2025

Volume	792,400
Average Volume	910,293
Open	1.0100
Previous Close	1.0100
Day's Range	0.9900 - 1.0200
52-Week Range	0.8000 - 2.8000
Beta	n/a
RSI	42.72
Earnings Date	Jun 9, 2025

About Inspire IVF PCL

Inspire IVF Public Company Limited operates an infertility treatment center in Thailand. The company offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments. It provides obstetrics and gynecology examinations, consulting, and advice, as well as age management medicine, health regeneration, blood dialysis, and blood filtration services. The company was incorporated in 2018 an...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2018
• Employees: 31
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IVF

Financial Performance

In 2024, Inspire IVF PCL's revenue was 108.34 million, a decrease of -11.26% compared to the previous year's 122.09 million. Earnings were 22.15 million, a decrease of -45.95%.